reference/15630789

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15630789

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase III\|Journal Article
endingPage	556
issn	1064-7481
issueIdentifier	5
pageRange	541-556
publicationName	The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry
startingPage	541
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_2b41d727b10855d87e77e19e4b0aea75
bibliographicCitation	Ochs-Ross R, Wajs E, Daly EJ, Zhang Y, Lane R, Lim P, Drevets WC, Steffens DC, Sanacora G, Jamieson C, Hough D, Manji H, Singh JB. Comparison of Long-Term Efficacy and Safety of Esketamine Nasal Spray Plus Oral Antidepressant in Younger Versus Older Patients With Treatment-Resistant Depression: Post-Hoc Analysis of SUSTAIN-2, a Long-Term Open-Label Phase 3 Safety and Efficacy Study. The American Journal of Geriatric Psychiatry. 2022 May;30(5):541–56. doi: 10.1016/j.jagp.2021.09.014.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ed0f2f957f4d8108926f8e9964fb5ed0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_33e7bf3a5c48217535f5579e789f7fca http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_17a6e511bc3b9b556eb281dc2b873a00 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_979b2ab702449fb1821d641b50998c2e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7a729fe839b86ac141e390ba79304980 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f3e070c033814bcc0e4f29b17582ee9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f30255de7a887d6e749991d56081ffc6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8390624e134c808d70774a6ae42174fc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_97532c84efa09050fa15e38a7e03db74 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a061ee419a7ca648dd1aba0c694e2982 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9137fe389d3788dfc8786b5f58f9a09a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_226ffa40f2843c667a7bda4178ed99e0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c2854eee10053abcf29eadb750ff582a
date	202205
identifier	https://pubmed.ncbi.nlm.nih.gov/34750057 https://doi.org/10.1016/j.jagp.2021.09.014
isPartOf	https://portal.issn.org/resource/ISSN/1064-7481 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20556
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Comparison of Long-Term Efficacy and Safety of Esketamine Nasal Spray Plus Oral Antidepressant in Younger Versus Older Patients With Treatment-Resistant Depression: Post-Hoc Analysis of SUSTAIN-2, a Long-Term Open-Label Phase 3 Safety and Efficacy Study
discusses	http://id.nlm.nih.gov/mesh/M000647133 http://id.nlm.nih.gov/mesh/M0545702 http://id.nlm.nih.gov/mesh/M0001384 http://id.nlm.nih.gov/mesh/M0011982
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D007649Q000008 http://id.nlm.nih.gov/mesh/D003863Q000188 http://id.nlm.nih.gov/mesh/D000928Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D004359Q000009 http://id.nlm.nih.gov/mesh/D000284 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D059085 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D008875
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7428 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8102 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11392 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID182137

Total number of triples: 53.